Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Voswinckel, R; Reichenberger, F; Gall, H; Schmehl, T; Gessler, T; Schermuly, RT; Grimminger, F; Rubin, LJ; Seeger, W; Ghofrani, HA; Olschewski, H.
Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension.
Pulm Pharmacol Ther. 2009; 22(1): 50-56.
Doi: 10.1016/j.pupt.2008.11.009
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-Autor*innen der Med Uni Graz
- Olschewski Horst
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Background: The stable prostanoid analogue treprostinil is approved as continuous infusion for treatment of pulmonary arterial hypertension. Unique drug characteristics may render this prostanoid feasible for inhalation therapy with a metered dose inhaler. Methods and results: Randomised open label investigation of acute haemodynamic effects, safety and tolerability of inhaled treprostinil delivered in seconds by a metered dose inhaler (MDI-TRE). Inhaled nitric oxide (NO) and MDI-TRE were applied once during right heart catheter investigation to 39 consecutive patients with pre-capillary pulmonary hypertension. Doses of 30 mu g, 45 mu g and 60 mu g MDI-TRE were investigated in separate groups of patients. Haemodynamics and blood gases were measured for 2 h following treprostinil application. Acute haemodynamic responses to NO and MDI-TRE were comparable. MDI-TRE significantly improved haemodynamics compared to placebo inhalation. MDI-TRE induced effects were comparable to a historical control group that inhaled treprostinil from an ultrasonic nebuliser. The 120 min area under the curve for PVR changes due to placebo, 30 mu g, 45 mu g or 60 mu g MDI-TRE was 1114 +/- 998, -870 +/- 940, -2450 +/- 2070 and -2000 +/- 900 min*%. Reduction of systemic vascular resistance and pressure were not clinically relevant. No significant side effects were observed. No impact on ventilation/perfusion matching by treprostinil was demonstrated in 5 patients with pre-existing gas exchange limitations by use of the multiple inert gas elimination technique. Conclusions: The application of inhaled treprostinil with a metered dose inhaler is feasible and well tolerated. It induced a sustained pulmonary selective vasodilatation. (c) 2008 Elsevier Ltd. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
- Administration, Inhalation -
- Aged -
- Antihypertensive Agents - administration and dosage
- Area Under Curve -
- Dose-Response Relationship, Drug -
- Epoprostenol - administration and dosage
- Female -
- Hemodynamics - drug effects
- Humans -
- Hypertension, Pulmonary - drug therapy
- Male -
- Metered Dose Inhalers -
- Middle Aged -
- Nitric Oxide - administration and dosage
- Vasodilation - drug effects
- Find related publications in this database (Keywords)
- Prostacyclin
- Pulmonary hypertension
- Pulmonary heart disease
- Treprostinil sodium
- Metered dose inhaler
- Aerosol